There are many TOUCH-approved sites across the country that provide TYSABRI infusions. These include infusion centers, specially equipped doctor's offices and infusion clinics within hospitals. The easy-to-use search tool below can help you find one.
You searched for infusion centers within: xx miles of ZIP Code: xxxxx
We provide information on infusion sites that are enrolled in the TOUCH Prescribing Program and administer TYSABRI. We do this for informational purposes only. Biogen Idec does not receive payment for this service and does not own, operate, or control any infusion site, nor do we endorse any particular site. If a doctor or infusion site would like to be removed from the database, please contact Patient Services at 800.456.2255.
Indication TYSABRI® (natalizumab) is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis. TYSABRI increases the risk of PML. When initiating and continuing treatment with TYSABRI, physicians should consider whether the expected benefit of TYSABRI is sufficient to offset this risk. See important information regarding the risk of PML with TYSABRI.